We track Merck Global Health Innovation Fund but have little verified detail yet.
At a glance
Merck Global Health Innovation Fund appears in 2 funding rounds tracked by ValueAddVC since 2026. Its most recent tracked deal was BigHat Biosciences' $75M Series C round (Sep 24, 2026).
Portfolio
2 totalRecent Investment Activity
2Track record: led 0 and participated in 2 of 2 tracked venture rounds · 2 in the last 12 months
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | BigHat Biosciences | Series C | Participated | $75M | — | DFJ GrowthLeadPremji InvestLeadCatalio Capital ManagementLG Technology Ventures8VCAndreessen HorowitzEli Lilly and CompanyMerck Global Health Innovation FundQuadrille CapitalGRIDS CapitalIntermountain VenturesSection 32Sigmas GroupAmgen VenturesAlexandria Venture InvestmentsDiscovery Ventures | BioSpace |
| Aug 11, 2026 | Infinimmune | Series A | Participated | $75M | — | Regeneron VenturesLeadMerck Global Health Innovation FundCivilization VenturesPear VCEverbright Biofund | Pulse story |
Sector / Stage Activity
Co-Investors
12Latest Pulse
Merck Global Health Innovation Fund FAQ
What companies has Merck Global Health Innovation Fund invested in?
Merck Global Health Innovation Fund's portfolio includes BigHat Biosciences, Infinimmune.
Who does Merck Global Health Innovation Fund co-invest with most?
In the rounds Value Add tracks, Merck Global Health Innovation Fund most often invests alongside 8VC (1 shared deal), Andreessen Horowitz (1 shared deal), Catalio Capital Management (1 shared deal), DFJ Growth (1 shared deal), Eli Lilly and Company (1 shared deal).
Sources & methodologyshow
- BioSpaceresearch database1 fact
- MedCity NewsValue Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.